Intervention
Tailored Intervention
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownPrehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and SurgeryNCT07819981 · 2027-02-24
NOT_YET_RECRUITINGWeb-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C TrialNCT07723235 · 2026-10-10
NOT_YET_RECRUITINGCommon conditions
Anatomic Stage I Breast Cancer AJCC v81Anatomic Stage II Breast Cancer AJCC v81Anatomic Stage III Breast Cancer AJCC v81Breast Carcinoma1Endometrial Carcinoma1Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v81Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v81Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v81
Leading sponsors
Trial status mix
NOT_YET_RECRUITING2
Phase mix
NA2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.